Exclusive: Advent, Avista near deal for UCB’s Kremers Urban

A consortium of buyout firms that includes Advent International Corp and Avista Capital Partners is in advanced talks to acquire UCB SA’s U.S. generic drugs unit Kremers Urban Pharmaceuticals Inc, people familiar with the matter told Reuters news service.